In the search for new therapeutic tools against neglected diseases produced by trypanosomatid parasites, and particularly against African Trypanosomiasis, whose etiological agent is Trypanosoma brucei, organoruthenium compounds with bioactive nitrofuran containing thiosemicarbazones (L) as co-ligands were obtained. Four ruthenium(II) complexes with the formula [Ru(2)(p-cymene)(2)(L)(2)]X(2), where X = Cl or PF(6), were synthesized and the crystal structures of two of them were solved by X-ray diffraction methods. Two of the complexes show significant in vitro growth inhibition activity against Trypanosoma brucei brucei and are highly selective towards trypanosomal cells with respect to mammalian cells (J774 murine macrophages). These promising results make the title organoruthenium compounds good lead candidates for further developments towards potential antitrypanosomal organometallic drugs.
In the search for new therapeutic tools against neglected diseases produced by trypanosomatid parasites, and particularly against African Trypanosomiasis, whose etiological agent is n class="Species">Trypanosoma brucei, organoruthenium compounds with bioactive nitrofuran containing thiosemicarbazones (L) as co-ligands were obtained. Four ruthenium(II) complexes with the formula [Ru(2)(p-cymene)(2)(L)(2)]X(2), where X = Cl or PF(6), were synthesized and the crystal structures of two of them were solved by X-ray diffraction methods. Two of the complexes show significant in vitro growth inhibition activity against Trypanosoma brucei brucei and are highly selective towards trypanosomal cells with respect to mammalian cells (J774murine macrophages). These promising results make the title organoruthenium compounds good lead candidates for further developments towards potential antitrypanosomal organometallic drugs.
Authors: Lucía Otero; Marisol Vieites; Lucía Boiani; Ana Denicola; Carolina Rigol; Lucía Opazo; Claudio Olea-Azar; Juan Diego Maya; Antonio Morello; R Luise Krauth-Siegel; Oscar E Piro; Eduardo Castellano; Mercedes González; Dinorah Gambino; Hugo Cerecetto Journal: J Med Chem Date: 2006-06-01 Impact factor: 7.446
Authors: Carolina Urquiola; Marisol Vieites; Gabriela Aguirre; Adoración Marín; Beatriz Solano; Gabriel Arrambide; Pabla Noblía; María Laura Lavaggi; María H Torre; Mercedes González; Antonio Monge; Dinorah Gambino; Hugo Cerecetto Journal: Bioorg Med Chem Date: 2006-05-18 Impact factor: 3.641
Authors: Diogo Rodrigo Magalhães Moreira; Ana Cristina Lima Leite; Ricardo Ribeiro dos Santos; Milena B P Soares Journal: Curr Drug Targets Date: 2009-03 Impact factor: 3.465
Authors: Eva Iniguez; Antonio Sánchez; Miguel A Vasquez; Alberto Martínez; Joanna Olivas; Aaron Sattler; Roberto A Sánchez-Delgado; Rosa A Maldonado Journal: J Biol Inorg Chem Date: 2013-07-24 Impact factor: 3.358
Authors: Alberto Martínez; Teresia Carreon; Eva Iniguez; Atilio Anzellotti; Antonio Sánchez; Marina Tyan; Aaron Sattler; Linda Herrera; Rosa A Maldonado; Roberto A Sánchez-Delgado Journal: J Med Chem Date: 2012-04-09 Impact factor: 7.446
Authors: Jaime Franco; Florencia Sardi; László Szilágyi; Katalin E Kövér; Krisztina Fehér; Marcelo A Comini Journal: Int J Parasitol Drugs Drug Resist Date: 2017-08-12 Impact factor: 4.077